First, healthcare, managed-care and medical-device platforms hiring commercial, product and regulatory counsel as internal minutes outrun outside counsel. Second, consumer, retail and industrial operators adding commercial and employment counsel for multi-state stacks. Third, banking and financial-services teams adding corporate, regulatory and litigation-management counsel. Fourth, AGC seats that combine people leadership with residual sector depth after a GC reorganisation.
Above the Law's 2025 readout of ACC/BLS data showed U.S. in-house counsel rising from about 78,000 in 2008 to 145,000 in 2024—nearly +90% against roughly 23% law-firm attorney growth. ACC's 2025 state analysis also noted consistent Midwest in-house concentration gains, including Wisconsin (+28%) and Illinois (+9%) on standardised ratios between 2019 and 2024. That public picture matches our Minneapolis mandate telemetry on the 15 closed in-house searches of the last three years: roughly 40% were healthcare, device or managed-care counsel, about 25% consumer or commercial counsel, about 20% corporate/M&A or finance, and the balance AGC, employment or litigation-management seats.
Live confidential work typically includes mid-level device product counsel, healthcare commercial counsel, corporate counsel for PE-backed platforms, and confidential replacements where the incumbent is still in seat. Candidate-side interest is highest among firm counsel at years 5–12 whose partnership path has narrowed. Absolute feeder supply is solid; HQ-scope geometry still decides who moves.